Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.

Bioโ€‘Rad Laboratories, Inc. (BIO) designs and sells instruments, reagents and software for lifeโ€‘science research and clinical diagnostics. The business is organised mainly into two segments: Life Science, which serves academic and industrial researchers, and Clinical Diagnostics, which supplies hospitals and clinical laboratories. Revenue benefits from recurring consumables and service contracts alongside new equipment sales, giving a mix of predictable and cyclical income. The company invests in R&D and occasionally grows through acquisitions, with global distribution and an installed base that supports aftermarket demand. Key risks include regulatory approvals, reimbursement dynamics in diagnostics, competition, foreignโ€‘exchange exposure and potential execution risks from integration or capital projects. Market cap is roughly $8.9bn. This summary is for educational purposes only and not personalised investment advice; investments can fall as well as rise and you should consider your own circumstances or consult a financial adviser.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts recommend buying Bio-Rad's stock with a target price of $366.2, indicating strong growth potential.

Above Average

Financial Health

Bio-Rad Laboratories shows strong revenue and cash flow, indicating solid financial performance and stability.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring BIO

Activist Sparks Life Science Shakeup

Activist Sparks Life Science Shakeup

Activist investor Engine Capital is pushing for a sale of life-sciences company Avantor after taking a significant stake. This move could spark a wave of M&A across the life-sciences supply industry, creating opportunities for competitor firms and other potential acquisition targets.

Published: August 11, 2025

Explore Basket

Why Youโ€™ll Want to Watch This Stock

๐Ÿ“ˆ

Recurring Consumables Appeal

A significant portion of revenue comes from consumables and service contracts, which can provide steady cash flow โ€” though demand can fluctuate with research funding and testing volumes.

๐ŸŒ

Global Customer Base

Sales span academic research, biotech and clinical labs worldwide, offering diversification across markets, but international exposure brings currency and regulatory risks.

โšก

R&D and Innovation

Continued investment in R&D and selective acquisitions can drive new product cycles, yet execution and integration risk mean outcomes are not assured.

Why invest with Nemo?

Nemo Logo Fade
๐Ÿ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

๐Ÿ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

๐Ÿ’ฐ

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

ABT

Abbott Laboratories

Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.

A

Agilent Technologies Inc.

Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.

ALGN

Align Technology Inc.

Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.

Frequently asked questions